| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Wim van den Brink | Q20650402 |
| Robin Room | Q22096670 | ||
| Bernard Le Foll | Q28480403 | ||
| Jürgen Rehm | Q59708828 | ||
| P2093 | author name string | Wayne Hall | |
| Pamela Sabioni | |||
| Benedikt Fischer | |||
| Cayley Russell | |||
| P2860 | cites work | The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study | Q21132482 |
| A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies | Q21260309 | ||
| Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings | Q21559698 | ||
| Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities | Q36571381 | ||
| North of England evidence based guidelines development project: methods of guideline development | Q36597559 | ||
| Chemistry, metabolism, and toxicology of cannabis: clinical implications. | Q36604757 | ||
| Going from evidence to recommendations | Q36645665 | ||
| Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review | Q36734538 | ||
| Health communication campaigns and their impact on behavior | Q36751147 | ||
| Socioeconomic status and health behaviors in adolescence: a review of the literature | Q36827231 | ||
| Lay epidemiology and the interpretation of low-risk drinking guidelines by adults in the United Kingdom | Q36886543 | ||
| Cannabis and tolerance: acute drug impairment as a function of cannabis use history | Q36937737 | ||
| Knowledge transfer and exchange: review and synthesis of the literature | Q37028400 | ||
| A meta-analysis of marijuana and alcohol use by socio-economic status in adolescents aged 10-15 years. | Q37212038 | ||
| Establishing legal limits for driving under the influence of marijuana | Q37218871 | ||
| Association between marijuana exposure and pulmonary function over 20 years | Q37343800 | ||
| Chronic toxicology of cannabis | Q37544803 | ||
| Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research | Q37561239 | ||
| Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010. | Q37612582 | ||
| Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity | Q37666477 | ||
| Effects of smoking cannabis on lung function | Q37920897 | ||
| Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. | Q37949991 | ||
| Different guidelines for different countries? On the scientific basis of low-risk drinking guidelines and their implications | Q37965867 | ||
| Synthetic cannabinoid intoxication: a case series and review | Q38044542 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
| Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies | Q22252228 | ||
| Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology | Q24602238 | ||
| An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions | Q24627250 | ||
| Marijuana use and motor vehicle crashes | Q24633868 | ||
| Cannabis effects on driving skills | Q26860495 | ||
| Adverse health effects of marijuana use | Q26861513 | ||
| The effectiveness of knowledge translation strategies used in public health: a systematic review | Q26863374 | ||
| Gone to Pot - A Review of the Association between Cannabis and Psychosis | Q26865311 | ||
| Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids | Q27010555 | ||
| Psychosocial Determinants of Cannabis Dependence: A Systematic Review of the Literature | Q28081913 | ||
| Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review | Q28238516 | ||
| Legalizing Cannabis: A physician's primer on the pulmonary effects of marijuana | Q28251649 | ||
| Adverse health effects of non-medical cannabis use | Q28261715 | ||
| The acute effects of cannabinoids on memory in humans: a review | Q28266863 | ||
| Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving | Q28484782 | ||
| Effects of quitting cannabis on respiratory symptoms | Q28603227 | ||
| "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans | Q30455650 | ||
| Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence | Q30558464 | ||
| Effects of cannabis on the adolescent brain | Q30653619 | ||
| Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function | Q30654825 | ||
| Designing effective nutrition interventions for adolescents | Q31043384 | ||
| Should burden of disease estimates include cannabis use as a risk factor for psychosis? | Q33507244 | ||
| Clinical guidelines: developing guidelines | Q33536430 | ||
| A cotwin-control analysis of drug use and abuse/dependence risk associated with early-onset cannabis use | Q33562500 | ||
| Structural MRI findings in long-term cannabis users: what do we know? | Q33621732 | ||
| Low-risk drinking guidelines: the scientific evidence. | Q33734096 | ||
| Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood | Q33750946 | ||
| A vision for cannabis regulation: a public health approach based on lessons learned from the regulation of alcohol and tobacco | Q33856784 | ||
| Long-term effects of cannabis on brain structure. | Q33923622 | ||
| Cannabis as a risk factor for psychosis: systematic review | Q33986870 | ||
| Cannabidiol--recent advances | Q34005880 | ||
| Persistent cannabis users show neuropsychological decline from childhood to midlife | Q34033362 | ||
| Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer | Q34114144 | ||
| Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis | Q34155916 | ||
| Cannabis use and mental health in young people: cohort study | Q34160355 | ||
| Cortical thickness and neurocognition in adolescent marijuana and alcohol users following 28 days of monitored abstinence. | Q34167970 | ||
| Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis | Q34239086 | ||
| Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. | Q34287396 | ||
| Effects of prenatal tobacco, alcohol and marijuana exposure on processing speed, visual-motor coordination, and interhemispheric transfer | Q34288306 | ||
| Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment | Q34304341 | ||
| Adolescent Brain Development and the Risk for Alcohol and Other Drug Problems | Q34336707 | ||
| Parents' use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. | Q34350465 | ||
| The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. | Q34353092 | ||
| The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review | Q34378704 | ||
| Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts. | Q34381806 | ||
| Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction | Q34415424 | ||
| Cannabis smoking and respiratory health: consideration of the literature. | Q34420153 | ||
| Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium | Q34425758 | ||
| Epidemiologic review of marijuana use and cancer risk | Q34438543 | ||
| A systematic review of the antipsychotic properties of cannabidiol in humans | Q34462024 | ||
| Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015. | Q34480453 | ||
| Assessing the Dangers of "Dabbing": Mere Marijuana or Harmful New Trend? | Q34480851 | ||
| Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study | Q34493623 | ||
| A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. | Q34501742 | ||
| Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis. | Q34501767 | ||
| Hippocampal harms, protection and recovery following regular cannabis use | Q34508645 | ||
| A literature review and meta-analyses of cannabis use and suicidality | Q34513869 | ||
| The effects of cannabis intoxication on motor vehicle collision revisited and revised. | Q34514247 | ||
| Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. | Q34514461 | ||
| Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. | Q34517446 | ||
| Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults | Q34524036 | ||
| Tests of causal linkages between cannabis use and psychotic symptoms | Q34555395 | ||
| Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs | Q34561272 | ||
| A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol | Q34561595 | ||
| Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis | Q34589855 | ||
| Cannabis use and later life outcomes | Q34592032 | ||
| Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications | Q34617484 | ||
| Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers | Q34639448 | ||
| Cannabis and psychomotor performance: a rational review of the evidence and implications for public policy | Q34642554 | ||
| The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning | Q34644193 | ||
| Cannabidiol in humans-the quest for therapeutic targets | Q34657897 | ||
| Young adult sequelae of adolescent cannabis use: an integrative analysis | Q34672949 | ||
| Long lasting consequences of cannabis exposure in adolescence | Q34764034 | ||
| Altered prefrontal and insular cortical thickness in adolescent marijuana users. | Q34775939 | ||
| The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study | Q34809059 | ||
| Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile | Q34875298 | ||
| Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. | Q35184674 | ||
| Prenatal marijuana exposure predicts marijuana use in young adulthood | Q35240861 | ||
| Genetic predisposition to schizophrenia associated with increased use of cannabis | Q35246819 | ||
| The implications of marijuana legalization in Colorado | Q35500385 | ||
| No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk. | Q35686659 | ||
| Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies | Q35774562 | ||
| Age of onset of marijuana use and executive function | Q35936433 | ||
| Cannabis effects on driving lateral control with and without alcohol | Q35952146 | ||
| Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis | Q35980486 | ||
| Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users | Q36062692 | ||
| The co-occurring use and misuse of cannabis and tobacco: a review | Q36097783 | ||
| Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. | Q36178411 | ||
| Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis | Q36471630 | ||
| Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships | Q36568260 | ||
| Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops | Q46726330 | ||
| The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood | Q47405586 | ||
| Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial | Q47869018 | ||
| Effects of Cannabis Use on Human Behavior: A Call for Standardization of Cannabis Use Metrics | Q47972640 | ||
| Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway | Q48209883 | ||
| Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults | Q48287666 | ||
| Gross morphological brain changes with chronic, heavy cannabis use. | Q48444995 | ||
| Cannabis use and suicidal ideation | Q48495192 | ||
| Parental occupation and childhood astrocytoma: results of a case-control study | Q48527572 | ||
| Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls | Q48855088 | ||
| Cannabis with high cannabidiol content is associated with fewer psychotic experiences | Q48868841 | ||
| High-potency marijuana impairs executive function and inhibitory motor control | Q48935782 | ||
| The combined effects of alcohol and cannabis on driving: Impact on crash risk. | Q50048296 | ||
| Cannabis legalization with strict regulation, the overall superior policy option for public health. | Q50597401 | ||
| Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. | Q50654868 | ||
| Unintentional Pediatric Exposures to Marijuana in Colorado, 2009-2015. | Q51315230 | ||
| Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy. | Q51551405 | ||
| Cannabis use and expression of mania in the general population. | Q51915718 | ||
| Early adolescent cannabis exposure and positive and negative dimensions of psychosis. | Q51937432 | ||
| Mental health of teenagers who use cannabis. Results of an Australian survey. | Q51959353 | ||
| Cannabis dependence and psychotic symptoms in young people | Q52024293 | ||
| A longitudinal study of cannabis use and mental health from adolescence to early adulthood | Q52278444 | ||
| A longitudinal study of the effects of adolescent cannabis use on high school completion. | Q52282401 | ||
| Reducing cannabis-impaired driving: is there sufficient evidence for drug testing of drivers? | Q52292202 | ||
| Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints? | Q52304787 | ||
| Assessing the public health impacts of legalizing recreational cannabis use in the USA. | Q52306753 | ||
| Does cannabis smoking predispose to lung bulla formation? | Q53076982 | ||
| Developing public health regulations for marijuana: lessons from alcohol and tobacco. | Q55058235 | ||
| High potency cannabis | Q57046993 | ||
| Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group) | Q69492294 | ||
| An evidence-based approach for establishing dietary guidelines | Q79609292 | ||
| Marijuana 'bong' smoking and tuberculosis | Q86528389 | ||
| Hidden formaldehyde in e-cigarette aerosols | Q86570106 | ||
| Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review. | Q38119509 | ||
| Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. | Q38133047 | ||
| Association of unintentional pediatric exposures with decriminalization of marijuana in the United States | Q38186173 | ||
| White matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies | Q38212959 | ||
| Cannabis use and mania symptoms: a systematic review and meta-analysis | Q38257026 | ||
| The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects | Q38317405 | ||
| A new method of cannabis ingestion: the dangers of dabs? | Q38417091 | ||
| Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. | Q38431693 | ||
| Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. | Q38722120 | ||
| Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review | Q38726957 | ||
| Evaluating the public health impacts of legalizing recreational cannabis use in the United States | Q38809105 | ||
| A Systematic Review of the Respiratory Effects of Inhalational Marijuana | Q38923287 | ||
| The prevalence of marijuana in suspected impaired driving cases in Washington state | Q39129947 | ||
| Cannabis policy reforms in the Americas: a comparative analysis of Colorado, Washington, and Uruguay | Q39169123 | ||
| The association between cannabis use and suicidality among men and women: A population-based longitudinal study. | Q39568587 | ||
| Early marijuana initiation: The link between prenatal marijuana exposure, early childhood behavior, and negative adult roles | Q39709038 | ||
| Adverse Effects of Cannabis on Adolescent Brain Development: A Longitudinal Study | Q39970622 | ||
| The burden of disease attributable to cannabis use in Canada in 2012. | Q40283819 | ||
| Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County | Q41326103 | ||
| Impact of age at onset of cannabis use on cannabis dependence and driving under the influence in the United States. | Q41646406 | ||
| Genetic and environmental contributions to cannabis dependence in a national young adult twin sample | Q42671142 | ||
| The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks. | Q42930353 | ||
| Cannabis use and educational achievement: findings from three Australasian cohort studies. | Q43067543 | ||
| Knowledge of drinking guidelines does not equal sensible drinking. | Q43264013 | ||
| Increased collision risk among drivers who report driving after using alcohol and after using cannabis. | Q43574167 | ||
| Cannabis use before age 15 and subsequent executive functioning | Q43849098 | ||
| Cannabis dependence in young adults: an Australian population study | Q43892478 | ||
| The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products | Q44004239 | ||
| Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study | Q44019275 | ||
| Pediatric marijuana exposures in a medical marijuana state | Q44251713 | ||
| Escalation of drug use in early-onset cannabis users vs co-twin controls | Q44281651 | ||
| Trajectories of adolescent alcohol and cannabis use into young adulthood | Q44334611 | ||
| Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. | Q44596499 | ||
| Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. | Q45037990 | ||
| Verbal learning and memory in adolescent cannabis users, alcohol users and non-users | Q45409302 | ||
| Cannabis and traffic collision risk: findings from a case-crossover study of injured drivers presenting to emergency departments | Q45857211 | ||
| The effects of cannabis and alcohol on simulated driving: Influences of dose and experience. | Q45947854 | ||
| Cannabis-induced psychosis associated with high potency "wax dabs". | Q46081550 | ||
| Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC). | Q46188729 | ||
| Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond | Q46240580 | ||
| Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis | Q46499968 | ||
| Increasing cannabis use: what we still need to know about its effects on the lung | Q46588237 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e1-e12 | |
| P577 | publication date | 2017-06-23 | |
| P1433 | published in | American Journal of Public Health | Q4744266 |
| P1476 | title | Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. | |
| P478 | volume | 107 |
| Q91893496 | "Guarding their practice": a descriptive study of Canadian nursing policies and education related to medical cannabis |
| Q95725946 | A research plan to define Canada's first low-risk gambling guidelines |
| Q88961657 | Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation |
| Q91789081 | Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders |
| Q90450513 | Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education |
| Q58798988 | Cannabis Legalization in Canada: Reflections on Public Health and the Governance of Legal Psychoactive Substances |
| Q89526801 | Cannabis and Pain Treatment-A Review of the Clinical Utility and a Practical Approach in Light of Uncertainty |
| Q92312460 | Cannabis and psychosis: revisiting a nineteenth century study of 'Indian Hemp and Insanity' in Colonial British India |
| Q94670060 | Cannabis in the workplace: What physicians need to know |
| Q91929735 | Cannabis industry and medical cannabis clinics need regulation |
| Q47552216 | Cannabis use among middle and high school students in Ontario: a school-based cross-sectional study |
| Q47126115 | Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment |
| Q64896573 | Co-use of cannabis, tobacco, and alcohol during adolescence: policy and regulatory implications. |
| Q90005540 | Evidence for THC versus CBD in cannabinoids |
| Q89340947 | Impact of cannabis legalization on treatment and research priorities for cannabis use disorder |
| Q94683803 | Incident testicular cancer in relation to using marijuana and smoking tobacco: A systematic review and meta-analysis of epidemiologic studies |
| Q92212851 | Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil |
| Q94670189 | Le cannabis en milieu de travail: Ce que les médecins doivent savoir |
| Q89859478 | Low-Risk Cannabis Use Is an Oxymoron |
| Q89389849 | Marijuana matters: reviewing the impact of marijuana on cognition, brain structure and function, & exploring policy implications and barriers to research |
| Q61808111 | Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients |
| Q58696988 | New Challenges: Developing Gendered and Equitable Responses to Involuntary Exposures to Electronic Nicotine Delivery Systems (ENDS) and Cannabis Vaping |
| Q60303341 | Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study |
| Q90968352 | Public health implications of legalising the production and sale of cannabis for medicinal and recreational use |
| Q50041116 | Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control. |
| Q91929754 | Réglementer l’industrie du cannabis et les cliniques de cannabis médical : Une nécessité |
| Q89446702 | Setting the Legal Age for Access to Cannabis in Canada: Bridging Neuroscience, Policy, and Prevention |
| Q57147982 | Sex Differences in the Association Between Cannabis Use and Suicidal Ideation and Attempts, Depression, and Psychological Distress Among Canadians |
| Q90362321 | Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder |
| Q64106960 | The Association between Cannabis Product Characteristics and Symptom Relief |
| Q90396906 | Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada |
| Q58087348 | Trends in treatment of problematic cannabis use in Ontario's specialized addiction treatment system from 2010/11 to 2015/16: a repeated cross-sectional study of a health administrative database |
| Q59192068 | Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings |
| Q90175219 | Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence |
Search more.